Market Report Source

Overview

Introduction

Sonus Pharmaceuticals’s main focus is to discover, develop and commercialize products for the treatment of diseases in the therapeutic area of oncology. The company seeks to build a franchise of oncology products through its own internal efforts.

Scope

Contains corporate strategy, value chain presence and SWOT Analysis Provides detailed business description, segment analysis, 5-year financial trends, key products and key competitors Includes information on suppliers/ partners, shareholding structure and key employees with biographies

Highlights

Sonus Pharmaceuticals is focused on the discovery, development and commercialization of pharmaceutical products for oncology indications. The company has only one program in its pipeline, namely, TOCOSOL Camptothecin, for the treatment of solid tumors. Sonus derives its revenues from collaboration and licensing agreements. These revenues are related to the collaboration agreement with Bayer Schering, under which Bayer Schering was granted worldwide exclusive license to market and promote TOCOSOL Paclitaxel and was responsible for clinical development and regulatory activities outside of the US. Sonus aims to apply its focus on advancing its second oncology product candidate, TOCOSOL Camptothecin, which was moved into a Phase I clinical trial in September 2006. In addition, it intends to identify and acquire products/technologies that are complementary to its focus in oncology in order to broaden the business and market opportunities.

Reasons to Purchase

Access all the important information and analysis on the company in a single report Understand company’s strengths, weaknesses, opportunities and threats along with business strategy and value chain Gain access to company’s adjusted five year financial data along with key ratios and market capitalization.

Table of Contents

Overview
Catalyst
Summary
Company Structure
Company Overview and Key Facts
Business Description
History
Locations and Subsidiaries
Company Financials
Stock Market Performance
P&L
Balance Sheet
Cash Flow
Business Segment Performance
Products & Services
Pipeline Products
Competitors and Strategic Business Relationships
Top Competitors
Shareholding Structure
Strategy
Company View
Corporate Strategy
SWOT Analysis
Overview
Strengths
Weaknesses
Opportunities
Threats
Value Chain Analysis
Overview
Discovery and Product Development
Key Employees
List of Key Employees
Key Employee Biographies
Financial and Operational Overview
Financial and Operational Overview
Appendix
Ask the analyst
Datamonitor consulting
Disclaimer

FIGURES
Figure 1: Sonus – Operating Revenue/Cost Analysis, 2002-2006 ($ Mn)

TABLES
Table 1: Sonus – Key Facts
Table 2: Sonus – Other Locations and Subsidiaries
Table 3: Sonus – Year-End Share Price and Market Capitalization, 2002-2006 ($)
Table 4: Sonus – Key Events Impacting Share Price Performance
Table 5: Sonus – Operating Revenue/Cost Analysis, 2002-2006 ($ Mn)
Table 6: Sonus – Operating Cost Ratio Analysis, 2002-2006 (% of total revenues)
Table 7: Sonus – Balance Sheet, 2002-2006 ($ Mn)
Table 8: Sonus – Cash Flow, 2002-2006 ($ Mn)
Table 9: Sonus – Revenue Breakdown, 2002-2006 ($ Mn)
Table 10: Sonus – In-house Pipeline Products
Table 11: Sonus – Top Competitors
Table 12: Sonus – Key Shareholders
Table 13: Sonus – SWOT Analysis Summary
Table 14: Sonus – Value Chain Analysis
Table 15: Sonus – Key Employees
Table 16: Sonus – Financial and Operational Overview